SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-17-069666
Filing Date
2017-11-20
Accepted
2017-11-20 17:31:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a17-27395_1s3.htm S-3 360066
2 EX-5.1 a17-27395_1ex5d1.htm EX-5.1 30392
3 EX-23.1 a17-27395_1ex23d1.htm EX-23.1 4114
4 GRAPHIC g273951kii001.jpg GRAPHIC 2434
  Complete submission text file 0001104659-17-069666.txt   399211
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221684 | Film No.: 171214860
SIC: 2834 Pharmaceutical Preparations